Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1987 1
1988 1
1989 2
1990 1
1991 2
1992 4
1993 2
1994 4
1995 2
1996 5
1997 10
1998 11
1999 4
2000 5
2001 8
2002 10
2003 8
2004 6
2005 2
2006 3
2007 4
2008 1
2009 5
2010 1
2011 1
2012 2
2013 5
2014 1
2015 3
2016 2
2017 3
2018 4
2019 3
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

122 results
Results by year
Filters applied: . Clear all
Page 1
Glycopeptide carboxamides active against vancomycin-resistant enterococci.
Zweifel MJ, Snyder NJ, Cooper RD, Nicas TI, Mullen DL, Butler TF, Rodriguez MJ. Zweifel MJ, et al. J Antibiot (Tokyo). 2003 Mar;56(3):289-95. doi: 10.7164/antibiotics.56.289. J Antibiot (Tokyo). 2003. PMID: 12760685 Free article.
Eremomycin pyrrolidide: a novel semisynthetic glycopeptide with improved chemotherapeutic properties.
Olsufyeva EN, Shchekotikhin AE, Bychkova EN, Pereverzeva ER, Treshalin ID, Mirchink EP, Isakova EB, Chernobrovkin MG, Kozlov RS, Dekhnich AV, Preobrazhenskaya MN. Olsufyeva EN, et al. Drug Des Devel Ther. 2018 Sep 10;12:2875-2885. doi: 10.2147/DDDT.S173923. eCollection 2018. Drug Des Devel Ther. 2018. PMID: 30237697 Free PMC article.
Novel semi-synthetic glycopeptide antibiotics active against methicillin-resistant staphylococcus aureus (MRSA) and vancomycin-resistant Enterococci (VRE): doubly-modified water-soluble derivatives of chloroorienticin B.
Yoshida O, Yasukata T, Sumino Y, Munekage T, Narukawa Y, Nishitani Y. Yoshida O, et al. Bioorg Med Chem Lett. 2002 Nov 4;12(21):3027-31. doi: 10.1016/s0960-894x(02)00664-9. Bioorg Med Chem Lett. 2002. PMID: 12372494
Structure-activity relationships in the series of eremomycin carboxamides.
Miroshnikova OV, Printsevskaya SS, Olsufyeva EN, Pavlov AY, Nilius A, Hensey-Rudloff D, Preobrazhenskaya MN. Miroshnikova OV, et al. J Antibiot (Tokyo). 2000 Mar;53(3):286-93. doi: 10.7164/antibiotics.53.286. J Antibiot (Tokyo). 2000. PMID: 10819300 Free article.
New semisynthetic glycopeptides MDL 63,246 and MDL 63,042, and other amide derivatives of antibiotic A-40,926 active against highly glycopeptide-resistant VanA enterococci.
Malabarba A, Ciabatti R, Scotti R, Goldstein BP, Ferrari P, Kurz M, Andreini BP, Denaro M. Malabarba A, et al. J Antibiot (Tokyo). 1995 Aug;48(8):869-83. doi: 10.7164/antibiotics.48.869. J Antibiot (Tokyo). 1995. PMID: 7592033 Free article.
122 results
Jump to page
Feedback